The Neonatal Kidney Collaborative (NKC) is an alliance of neonatologists and pediatric nephrologists dedicated to improving outcomes in neonates at risk for acute kidney injury. NKC's mission is to improve the understanding and outcomes associated with kidney health in newborns globally. Its vision is to improve the lives of babies worldwide by performing high-quality clinical research, providing meaningful education to clinicians, enabling providers with safe/effective therapies, and advocating for neonates at risk for kidney disease.

Spearheaded by Dr. David Askenazi, the group has developed a robust infrastructure to support collaboration among an international network of neonatologists, pediatric nephrologists, obstetricians and pediatricians. The NKC is currently engaged in a variety of multi-center studies supported by this multidisciplinary approach.

Dr. Askenazi also works closely with Dr. Namasivayam Ambalavanan, MD, Director of the Translational Research in Normal & Disordered Development (TReNDD) Program, a collaborative group of investigators applying state of the art biological approaches to understanding human disorders of organogenesis.